Determine time and amount of ingestion of heavy metal (arsenic, lead) or time and amount of ingestion of gold.
Assess patient for symptoms of toxicity from ingested substance.
Monitor BP and pulse throughout therapy. Systolic BP may rise, and tachycardia may occur 1530 min after administration. BP usually returns to normal within 2 hr.
Monitor intake and output and notify physician if significant discrepancies occur or if urine output decreases. Alkalinization of urine may be used to prevent nephrotoxicity.
Monitor temperature throughout therapy. May cause fever in children after 2nd or 3rd dose, which persists until discontinuation of therapy.Lab Test Considerations
May cause decreased values of 131I thyroid uptake if test is performed during or immediately following dimercaprol therapy.